From: Impact of DOTS expansion on tuberculosis related outcomes and costs in Haiti
 |  |  | SAVINGS in $US MILLIONS WITH DOTS EXPANSION * | |
---|---|---|---|---|
 |  |  | PERSPECTIVE |  |
PARAMETER VARIED | CHANGE | NEW VALUE | SOCIETAL | GOVERNMENT |
Base Case (from Table 4) | Base | Base | ($131) | ($4) |
Initial DOTS investment | Double | $8.4 million total | ($126) | ($0) |
Annual DOTS maintenance | Double | $722,000 per year | ($128) | ($1) |
Annual DOTS maintenance + cost of TB drugs | Double both | $847,900 per year | ($128) | ($1) |
Foreign Donor Pays: Initial + annual + TB drugs | Eliminate all three | $8.44 million + $847,000 per year | ($138) | ($11) |
Change average duration of hospitalization | Decrease with DOTS, increase with Non-DOTS | 3 days – DOTS 60 days non-DOTS | ($165) | ($29) |
Single (SDR) and Multi (MDR) Drug resistance | Double prevalence of drug resistance | SDR : 40% MDR : 0.6% | ($131) | ($4) |
Impact of DOTS expansion on TB incidence in subsequent years | None 1/3 of base 2/3 of base | 0% annual decline 2% annual decline 4% annual decline | ($61) ($88) ($111) | $ 14 * $ 7* $ 1* |